Emergency Use Authorization
- All
- News
- Videos
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Crypto Transactions Under Scanner as Canada Invokes Emergency Powers to Counter Truckers’ Blockade
Canadian government authorities will now make use of anti-cash laundering and terrorist financing guidelines that may result in the seizure of cryptocurrencies should they be found financing protestors and prolonging the "illegal" truckers’ blockade.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
US Gives Full Approval To Moderna's COVID-19 Vaccine For Adults
The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's COVID19 "Spikevax" vaccine, which had previously received an emergency use authorization in the United States.
-
Covishield, Covaxin Cleared For Market Approval By Expert Panel
An expert panel of India's central drug authority today recommended granting regular market approval to Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
Serum Institute Thanks Centre For Emergency Use Approval For Covovax
Serum Institute of India on Tuesday expressed gratitude to the Union Health Ministry for granting Emergency Use Authorization for its COVID-19 vaccine Covovax.
-
Covovax, Serum Institute's Covid Vaccine, Recommended For Approval: Report
An expert panel of the country's central drug authority has recommended granting Emergency Use Authorisation to Serum Institute's Covid vaccine 'Covovax' with certain conditions, official sources said on Monday.
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
-
China PCR-Test Purchases Spiked Just Before First Covid Cases: Report
The Chinese province that was the initial epicenter of the Covid-19 outbreak made significant purchases of equipment used to test for infectious diseases months before Beijing notified international authorities of the emergence of a new coronavirus.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Crypto Transactions Under Scanner as Canada Invokes Emergency Powers to Counter Truckers’ Blockade
Canadian government authorities will now make use of anti-cash laundering and terrorist financing guidelines that may result in the seizure of cryptocurrencies should they be found financing protestors and prolonging the "illegal" truckers’ blockade.
-
Biological E's Corbevax Gets Expert Panel's Approval For Teens: Report
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
-
US Gives Full Approval To Moderna's COVID-19 Vaccine For Adults
The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna's COVID19 "Spikevax" vaccine, which had previously received an emergency use authorization in the United States.
-
Covishield, Covaxin Cleared For Market Approval By Expert Panel
An expert panel of India's central drug authority today recommended granting regular market approval to Covishield and Covaxin, which are currently only authorised for emergency use in the country, subject to certain conditions, official sources said
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
Serum Institute Thanks Centre For Emergency Use Approval For Covovax
Serum Institute of India on Tuesday expressed gratitude to the Union Health Ministry for granting Emergency Use Authorization for its COVID-19 vaccine Covovax.
-
Covovax, Serum Institute's Covid Vaccine, Recommended For Approval: Report
An expert panel of the country's central drug authority has recommended granting Emergency Use Authorisation to Serum Institute's Covid vaccine 'Covovax' with certain conditions, official sources said on Monday.
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
-
China PCR-Test Purchases Spiked Just Before First Covid Cases: Report
The Chinese province that was the initial epicenter of the Covid-19 outbreak made significant purchases of equipment used to test for infectious diseases months before Beijing notified international authorities of the emergence of a new coronavirus.
